VYNE Therapeutics (VYNE) EPS (Basic) (QoQ) (2017 - 2025)
VYNE Therapeutics (VYNE) EPS (Basic) (QoQ) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | VYNE Therapeutics | 1.19 Bn | 1.16 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 0.20% |
| Mar 31, 2025 | 0.20% |
| Jun 30, 2024 | -37.48% |
| Mar 31, 2024 | 94.64% |
| Dec 31, 2023 | 97.76% |
| Sep 30, 2023 | -2,458.75% |
| Jun 30, 2023 | -98.84% |
| Mar 31, 2023 | 99.55% |
| Dec 31, 2022 | -981.54% |
| Sep 30, 2022 | 15.35% |
| Jun 30, 2022 | -101.72% |
| Mar 31, 2022 | 488.33% |
| Dec 31, 2021 | 53.88% |
| Sep 30, 2021 | 25.04% |
| Jun 30, 2021 | 9.22% |
| Mar 31, 2021 | 72.32% |
| Dec 31, 2020 | -21.33% |
| Sep 30, 2020 | 87.80% |
| Jun 30, 2020 | -27.60% |
| Mar 31, 2020 | -49.42% |